doxifluridine has been researched along with Hematologic Malignancies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiba, K; Horikoshi, N; Saotome, T; Yoshida, N | 1 |
1 review(s) available for doxifluridine and Hematologic Malignancies
| Article | Year |
|---|---|
[Oral cancer chemotherapy in the clinic].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Floxuridine; Hematologic Neoplasms; Humans; Melphalan; Quality of Life; Tamoxifen; Tegafur; Uracil | 2000 |